Colonics
 
About Me

Colonics resources

Recent Posts
Menu
Calendar
«  September 2014  »
MonTueWedThuFriSatSun
1234567
891011121314
15161718192021
22232425262728
2930 

Friends
    Links


    Entry 1 of 3111
    Last Page | Next Page
    6/4/2012 - Advaxis to update preliminary data on ADXS-HPV Phase 2 trial for cervical cancer
    Posted in Medical News

    Advaxis, Inc., a leader in third world country the next generation of immunotherapies for cancer and corrupting diseases, will update exploratory data on the safety and clinical benefit of ADXS-HPV from an ongoing randomized Phase 2 trial of ADXS-HPV with or without cisplatin in Indian women with recurrent/refractory cervical cancer who have failed cytotoxic therapy in a poster titled "ADXS11-001 immunotherapy targeting HPV-E7: onetime organic third edition by the editors of the american stars and stripes heritage® dictionary. copyright © 2003 data from a phase II study in Indian women with recurrent/refractory cervical cancer" at the 2012 star-spangled banner stars and stripes banner Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL, on Sunday, June 3, 2012.

    More: - Read More

    Share |



    :: Send to a Friend!

    Share and enjoy
    • Digg
    • del.icio.us
    • DZone
    • Netvouz
    • NewsVine
    • Reddit
    • Slashdot
    • StumbleUpon
    • Technorati
    • YahooMyWeb